267 related articles for article (PubMed ID: 23468933)
1. Cysteine (C)-x-C receptor 4 undergoes transportin 1-dependent nuclear localization and remains functional at the nucleus of metastatic prostate cancer cells.
Don-Salu-Hewage AS; Chan SY; McAndrews KM; Chetram MA; Dawson MR; Bethea DA; Hinton CV
PLoS One; 2013; 8(2):e57194. PubMed ID: 23468933
[TBL] [Abstract][Full Text] [Related]
2. A feed-forward loop between nuclear translocation of CXCR4 and HIF-1α promotes renal cell carcinoma metastasis.
Bao Y; Wang Z; Liu B; Lu X; Xiong Y; Shi J; Li P; Chen J; Zhang Z; Chen M; Wang L; Wu Z
Oncogene; 2019 Feb; 38(6):881-895. PubMed ID: 30177838
[TBL] [Abstract][Full Text] [Related]
3. The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor.
Kasina S; Macoska JA
Mol Cell Endocrinol; 2012 Apr; 351(2):249-63. PubMed ID: 22245379
[TBL] [Abstract][Full Text] [Related]
4. A novel cross-talk between CXCR4 and PI4KIIIα in prostate cancer cells.
Sbrissa D; Semaan L; Govindarajan B; Li Y; Caruthers NJ; Stemmer PM; Cher ML; Sethi S; Vaishampayan U; Shisheva A; Chinni SR
Oncogene; 2019 Jan; 38(3):332-344. PubMed ID: 30111818
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression.
Coke CJ; Scarlett KA; Chetram MA; Jones KJ; Sandifer BJ; Davis AS; Marcus AI; Hinton CV
J Biol Chem; 2016 May; 291(19):9991-10005. PubMed ID: 26841863
[TBL] [Abstract][Full Text] [Related]
7. Cyclophilin A is required for CXCR4-mediated nuclear export of heterogeneous nuclear ribonucleoprotein A2, activation and nuclear translocation of ERK1/2, and chemotactic cell migration.
Pan H; Luo C; Li R; Qiao A; Zhang L; Mines M; Nyanda AM; Zhang J; Fan GH
J Biol Chem; 2008 Jan; 283(1):623-637. PubMed ID: 17991743
[TBL] [Abstract][Full Text] [Related]
8. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
[TBL] [Abstract][Full Text] [Related]
9. Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro.
Frigo DE; Sherk AB; Wittmann BM; Norris JD; Wang Q; Joseph JD; Toner AP; Brown M; McDonnell DP
Mol Endocrinol; 2009 Sep; 23(9):1385-96. PubMed ID: 19460858
[TBL] [Abstract][Full Text] [Related]
10. Establishment of CXCR4-small interfering RNA retrovirus vector driven by human prostate-specific antigen promoter and its biological effects on prostate cancer in vitro and in vivo.
Du YF; Shi Y; Xing YF; Zeng FQ
J Cancer Res Clin Oncol; 2008 Nov; 134(11):1255-64. PubMed ID: 18431597
[TBL] [Abstract][Full Text] [Related]
11. Nuclear transport signals control cellular localization and function of androgen receptor cofactor p44/WDR77.
Gu Z; Zhou L; Gao S; Wang Z
PLoS One; 2011; 6(7):e22395. PubMed ID: 21789256
[TBL] [Abstract][Full Text] [Related]
12. NMMHC-IIA-dependent nuclear location of CXCR4 promotes migration and invasion in renal cell carcinoma.
Xu Z; Li P; Wei D; Wang Z; Bao Y; Sun J; Qu L; Wang L
Oncol Rep; 2016 Nov; 36(5):2681-2688. PubMed ID: 27634189
[TBL] [Abstract][Full Text] [Related]
13. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
[TBL] [Abstract][Full Text] [Related]
14. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
[TBL] [Abstract][Full Text] [Related]
15. [Establishment of RNA interfering retrovirus vector targeting CXCR4 gene driven by human prostate-specific antigen promoter and its biological effects on prostate cancer cells].
Du YF; Xing YF; Zeng FQ; Lu P; Liu XY; Xiao YJ
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):489-94. PubMed ID: 18069626
[TBL] [Abstract][Full Text] [Related]
16. Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells.
Chetram MA; Odero-Marah V; Hinton CV
Mol Cancer Res; 2011 Jan; 9(1):90-102. PubMed ID: 21076047
[TBL] [Abstract][Full Text] [Related]
17. EphB4 localises to the nucleus of prostate cancer cells.
Mertens-Walker I; Lisle JE; Nyberg WA; Stephens CR; Burke L; Rutkowski R; Herington AC; Stephenson SA
Exp Cell Res; 2015 Apr; 333(1):105-15. PubMed ID: 25724901
[TBL] [Abstract][Full Text] [Related]
18. Nuclear translocation of ADAM-10 contributes to the pathogenesis and progression of human prostate cancer.
Arima T; Enokida H; Kubo H; Kagara I; Matsuda R; Toki K; Nishimura H; Chiyomaru T; Tatarano S; Idesako T; Nishiyama K; Nakagawa M
Cancer Sci; 2007 Nov; 98(11):1720-6. PubMed ID: 17727679
[TBL] [Abstract][Full Text] [Related]
19. PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling.
Conley-LaComb MK; Saliganan A; Kandagatla P; Chen YQ; Cher ML; Chinni SR
Mol Cancer; 2013 Jul; 12(1):85. PubMed ID: 23902739
[TBL] [Abstract][Full Text] [Related]
20. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
